A Cause For Community

by Elizabeth Elfenbein, Columnist, February 3, 2017 We live in a patient-empowered world. People understand their healthcare challenges like never before. They become mini-experts during their journey to getting diagnosed. Yet, once a patient arrives at their diagnosis, they reach an inflection point and are suddenly alone with their experience. That’s where communities come in.Read More

[Continue reading…]

Emptying the ‘New Asylums’

On February 6, 2017 the American Enterprise Institute presented a panel discussion, Emptying the ‘new asylums’: A model for moving mentally ill inmates out of jail. Doris A. Fuller, chief of Research and Public Affairs for the Treatment Advocacy Center, presented the findings of Treatment Advocacy Center’s latest groundbreaking report, Emptying the ‘New Asylums‘. DorisRead More

[Continue reading…]

SARDAA Awarded Donation of $9000 From the Shon & John Cruise Wedding

Sincerest gratitude to the Bride and Groom and their wedding guests for their compassionate support of SARDAA. John and Shon Cruise selflessly asked their guests to donate to two charities in lieu of personal gifts to attend their reception. Thank you all for the generous $9,000 gift!!! Please attend the Hearing Voices of Support ExperientialRead More

[Continue reading…]

Federal Judge Sees New York State Conspiracy to Thwart Care for Mentally Ill

A federal judge in Brooklyn has accused state officials of secretly trying to subvert a landmark court order to improve care for thousands of mentally ill residents of New York City. Three years ago, U.S. District Judge Nicholas Garaufis ended a prolonged lawsuit against New York state by ordering the Department of Health to beginRead More

[Continue reading…]

Higher Death Rate Among Youth with First Episode Psychosis

A new study shows that young people experiencing first episode psychosis have a much higher death rate than previously thought. Researchers analyzed data on approximately 5,000 individuals aged 16-30 with commercial health insurance who had received a new psychosis diagnosis, and followed them for the next 12 months. They found that the group had aRead More

[Continue reading…]

Emptying the ‘New Asylums’

On February 6, 2017 the American Enterprise Institute presented a panel discussion, Emptying the ‘new asylums’: A model for moving mentally ill inmates out of jail.Doris A. Fuller, chief of Research and Public Affairs for the Treatment Advocacy Center, presented the findings of Treatment Advocacy Center’s latest groundbreaking report, Emptying the ‘New Asylums‘. Doris andRead More

[Continue reading…]

A Cause For Community

by Elizabeth Elfenbein, Columnist, February 3, 2017 We live in a patient-empowered world. People understand their healthcare challenges like never before. They become mini-experts during their journey to getting diagnosed. Yet, once a patient arrives at their diagnosis, they reach an inflection point and are suddenly alone with their experience. That’s where communities come in.Read More

[Continue reading…]

Impaired Glucose Homeostasis in First-Episode Schizophrenia; A Systematic Review and Meta-analysis

Findings  In this meta-analysis of 14 case-control studies comprising 1345 participants, individuals with first-episode schizophrenia had elevated fasting plasma glucose levels, elevated plasma glucose levels after an oral glucose tolerance test, and elevated fasting plasma insulin levels,as well as greater insulin resistance compared with healthy individuals serving as controls. To read more, please click here.Read More

[Continue reading…]

Blocking Overactive Enzyme Could Treat Symptoms of Schizophrenia

By Brain and Behavior Research Foundation New research suggests that cognitive and behavioral symptoms of schizophrenia may stem at least in part from elevated levels of an enzyme called STEP, which is also thought to be overactive in the brains of people with Parkinson’s disease and Alzheimer’s disease. Experiments in cells collected from patients andRead More

[Continue reading…]

Dr. Carrie Bearden, CAPPS & the NAPLS: Early Detection and Intervention for Psychosis

Under Dr. Bearden’s leadership, CAPPS has revealed new evidence supporting biomarkers for oncoming psychosis, and provided life-saving treatment for hundreds of youth at risk. Psychosis is one of the most distressing and debilitating mental health symptoms one can experience, and the earlier someone afflicted receives treatment, the better the potential outcome. The best-case scenario:Read More

[Continue reading…]